In a patient with classic biliary right upper quadrant pain, elevated liver function tests, and extra‑hepatic biliary dilation (common bile duct ≈8 mm), which type of sphincter of Oddi dysfunction is most likely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sphincter of Oddi Dysfunction Type I

This patient most likely has Type I sphincter of Oddi dysfunction (SOD), characterized by the complete triad of biliary-type pain, elevated liver function tests, and dilated common bile duct (≥8 mm). 1, 2, 3

Classification Framework

The Milwaukee classification stratifies SOD into three distinct types based on objective findings:

Type I SOD (Most Likely in This Patient)

  • Biliary pain (classic right upper quadrant)
  • Elevated liver enzymes (present in this case)
  • Dilated common bile duct (≥8 mm, present in this case)
  • Frequency of manometric abnormalities: 65-95% 3
  • Primarily due to sphincter stenosis rather than dyskinesia

Type II SOD

  • Biliary pain plus only one objective finding (either elevated enzymes OR duct dilation, but not both)
  • Frequency of manometric abnormalities: 50-63% 3

Type III SOD

  • Biliary pain alone without objective findings
  • Frequency of manometric abnormalities: 12-28% 3
  • Most controversial and least likely to benefit from intervention

Clinical Significance for This Patient

Type I SOD has the most straightforward management pathway. 3 The presence of all three criteria (pain, elevated LFTs, and CBD ≥8 mm) provides sufficient diagnostic certainty that:

  • Sphincter of Oddi manometry is NOT required before proceeding to treatment 3
  • Endoscopic sphincterotomy is indicated without additional invasive testing 3
  • Success rates are highest in this subgroup compared to Types II and III

Important Diagnostic Considerations

Before confirming Type I SOD, exclude:

  • Choledocholithiasis (including microlithiasis) - can present identically 4
  • Malignancy - particularly cholangiocarcinoma in dominant strictures
  • Primary sclerosing cholangitis - if chronic presentation
  • Pancreaticobiliary maljunction - congenital anomaly 5

The clinical presentation of Type I SOD and occult biliary microlithiasis can be indistinguishable, with both responding similarly to biliary sphincterotomy (75% vs 67% pain resolution) 4. However, the presence of CBD dilation (8 mm) makes Type I SOD the more likely diagnosis, as microlithiasis typically causes intermittent rather than persistent dilation.

Pathophysiology

Type I SOD involves sphincter stenosis with fibrosis of the sphincter of Oddi, creating functional obstruction to pancreaticobiliary flow 6, 1. This structural change can be visualized with optical coherence tomography showing thickened, hyper-reflective fibro-muscular layers 6.

References

Research

Sphincter of Oddi Dysfunction.

Current treatment options in gastroenterology, 2005

Research

Sphincter of Oddi dysfunction.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003

Research

Investigation of Oddi sphincter structure by optical coherence tomography in patients with biliary-type 1 dysfunction: a pilot in vivo study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.